New Delhi: India could join the 26 countries to approve Russia’s Sputnik V COVID-19 vaccine in the next few weeks, RIA news agency cited India’s ambassador to Moscow as saying on Monday.
The trials of the vaccine have been started in small batches by India’s Dr. Reddy’s Laboratories Ltd. The lab had earlier stated that Sputnik V meets the primary safety requirements for phase-2 clinical trials in India.
The mid-stage trial data have been submitted to the drug regulator.
The Lancet medical journal stated that the Russian vaccine is more effective than the Chinese ones, and it has 91.6 per cent success rate.
The Sputnik V can be stored in a fridge unlike Pfizer and Moderna’s vaccines.
In September 2020, Dr. Reddy’s and Russian Direct Investment Fund (RDIF) entered into a partnership to conduct its clinical trials.
Also Read: First Trial: Oxford COVID-19 Vaccine To Be Tested On Children
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…
Mumbai: Recently, some morphed pictures of actress Shweta Tiwari and her good friend Vishal Aditya…
Phulbani: Two tribal men were sentenced to life imprisonment by a special court in Odisha's…
New Delhi: It’s been just over two months since Atishi took oath as Delhi’s chief…
Bhubaneswar: In a moment of pride for AIIMS Bhubaneswar, Dr Manita Tamang, a final-year Senior…
Imphal: In view of the surge in violence in troubled Manipur, the Central government will send…
New Delhi/Bhubaneswar: The 7th edition of Odisha Parba got off to a colourful start in…